| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |